Prevalence of anosmia and ageusia symptoms among long-term effects of COVID-19.


Authors: Moraschini V1, Reis D1, Sacco R2, Calasans-Maia MD3 COVID‐19 is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that currently presents the greatest, most challenging health concern worldwide.…[...]

Characteristics of SARS-CoV-2 and COVID-19


Authors: Ben Hu, Hua Guo, Peng Zhou & Zheng-Li Shi  Nature Reviews Microbiology volume 19, pages141–154 (2021) Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly transmissible and pathogenic coronavirus that emerged in late 2019…[...]

COVID-19 related concerns of people with long-term respiratory conditions: a qualitative study


Authors: Keir E. J. Philip,  Bradley Lonergan, Andrew Cumella, Joe Farrington-Douglas, Michael Laffan & Nicholas S. Hopkinson BMC Pulmonary Medicine volume 20, Article number: 319 (2020)  Abstract Background The COVID-19 pandemic is having profound psychological impacts on populations globally, with increasing…[...]

The characteristics and evolution of pulmonary fibrosis in COVID-19 patients as assessed by AI-assisted chest HRCT


Authors: Jia-Ni Zou , Liu Sun , Bin-Ru Wang , You Zou , Shan Xu, Yong-Jun Ding, Li-Jun Shen, Wen-Cai Huang, Xiao-Jing Jiang, Shi-Ming Chen  Published: March 23, 2021 https://doi.org/10.1371/journal.pone.0248957 Abstract The characteristics and…[...]

The incidence, clinical characteristics, and outcomes of pneumothorax in hospitalized COVID-19 patients: A systematic review


Authors: Woon H. Chong,a,⁎Biplab K. Saha,bKurt Hu,c and Amit Chopraa Abstract Background Pneumothorax has been frequently described as a complication of COVID-19 infections. Objective In this systematic review, we describe the incidence,…[...]

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease


Authors: Timothy Cardozo 1 and Ronald Veazey 2 Abstract Aims of the study Patient comprehension is a critical part of meeting medical ethics standards of informed consent in study designs. The aim of the…[...]

U.S. probing Moderna vaccine for higher heart inflammation risk – Washington Post


Authors: Reporting by Shubham Kalia in Bengaluru; Editing by Krishna Chandra Eluri and Ramakrishnan M. Aug 19 (Reuters) - U.S. health officials are investigating reports that Moderna Inc's (MRNA.O) COVID-19 vaccine may…[...]

Scientists blast U.S. push for Covid vaccine booster shots as premature, say data isn’t compelling


PUBLISHED THU, AUG 19 20211:44 PM EDTUPDATED THU, AUG 19 20216:27 PM EDT Authors: Berkeley Lovelace Jr.@BERKELEYJR KEY POINTS Scientists sharply criticized the Biden administration’s push to widely distribute Covid…[...]

US Covid-19 Breakthrough Infections-are-Uncommon Rising Considerably and D-19 Breakthrough Infections are Uncommon, Rising Considerably, and Sort of Okay


Authors: PETER WEBER 5:20 AM The Biden administration is advising eight-month booster shots for Americans vaccinated with the Pfizer and Moderna COVID-19 vaccines because the Delta variant, which now accounts for about 98.8…[...]